Comment on this article
A
Neighorhood for Cures
The
opening of the Congress Avenue Building, the largest campus structure
in more than 70 years, adds desperately needed laboratory and teaching
space to the School of Medicine and brings together previously far-flung
scientists to join forces and find cures for common diseases.
March 2003
by
Marc Wortman
Marc
Wortman's article about genetically altered rodents, "The Magical
Medical Mouse," appeared in March 2000.
Child
psychiatrist Matthew State, MD, '01PhD specializes in finding the causes of disorders that show up early
in life, including devastating conditions like autism, obsessive-compulsive
disorder, and Tourette's syndrome. But last month he left behind
his headquarters in the Child Study Center, where he worked alongside
other child psychiatrists, for a spot in the School of Medicine's
new Congress Avenue Building.
The CAB, with its state-of-the-art
laboratories and classrooms, is the largest facility the Medical
School has ever built, and at 457,000 square-feet, it is only slightly
smaller in teatryrms of floor space than Yale's two largest buildings,
Payne Whitney Gymnasium and the Sterling Memorial Library. But for
State and other scientists, it's not the new space that matters
most. Rather, it's the neighborhood.
"It's important to
have the right resources, space, and equipment for your research,"
says State. "But what sets the CAB apart is the intellectual environment."
| |
"To
live in the midst of scientists who have worked on these
problems is an amazing opportunity."
|
The assistant professor
of genetics will share his new laboratory with scientists who, for
the most part, know little about neuropsychiatric disorders that
tend to show up before adulthood. But his colleagues can sleuth
out the complex links between a person's genetic inheritance and
environment that may lead to disease. The conversations State has
with fellow researchers in the lab and the halls will be essential
as he seeks to break new ground in tackling the childhood disorders.
"The CAB," he says, "is an embodiment of exactly why I looked outside
child psychiatry. To live in the midst of scientists who have worked on these problems
is an amazing opportunity."
The hope that such
collaborations could have a major impact on science and health led
Yale to make an unprecedented investment in constructing the new
laboratory and teaching complex. And State will be far from alone
in drawing on those around him for help in finding new ways to diagnose
and treat currently intractable diseases.
When it opened last
month, the CAB added about 25 percent more lab space to meet the
needs of 700 of the medical school's scientists. The facility also
includes technologically advanced teaching laboratories for the
136 first-year medical and physician associate students. The building,
the biggest Yale has constructed in more than 70 years, is the Medical
School's response to a shortage of lab space able to meet the demands
of modern research and teaching. At a price tag of $176.6 million,
it represents Yale's single largest capital investment ever and
a big part of the half-billion-dollar commitment made by President
Richard Levin in 2000 to expand and renew Yale's medical facilities
over the next decade.
Many
consider the CAB long overdue and, as large as it is, only a first
step for a school that has in the past struggled to meet
the space and research needs of its faculty and students. In fact,
the lack of room for expansion had begun to undermine the work of
one of the nation's preeminent biomedical centers. But though nobody
on campus questioned the need for space, some observers questioned
whether it would ever get built.
In 1998, medical school
dean David A. Kessler, MD warned that the School faced "a critical
shortage of space . so pronounced that investigators have had
to curtail their research -- in a few cases even return grants --
because of a lack of space in which to work." This lack had begun
to erode the school's reputation and, during an era of unprecedented
growth in public investment in biomedical science, it also undermined
the ability to compete for research grants. Over the past five years,
the budget of the National Institutes of Health (NIH) has more than
doubled. But while the Medical School ranks fifth among its peers
in total NIH grant awards -- $228 million in fiscal 2001 -- "Yale
has not gotten the share of the growing NIH budget it should have,"
says Arthur Broadus, MD, the Ensign Professor of Medicine and chief
of the section of endocrinology in the department of internal medicine.
Along with Carolyn Slayman, deputy dean for academic and scientific
affairs, Broadus co-chaired the committee that planned the new building.
As Yale attempted to
get the project off the ground, competing schools invested substantially
in science. The University of Pennsylvania and Harvard each built
four major research buildings in the past few years. But Yale has
not added new medical laboratory facilities since the opening of
the Boyer Center for Molecular Medicine in 1991.
| |
Yale
scientists were lured
away by competitors that offered additional lab space.
|
Much of the NIH budget
increase went to fund large-scale research programs, such as the
Human Genome Project, which Yale did not have space to accommodate.
Without room to grow, a number of scientists, particularly younger
investigators, were lured away by competitors that offered additional
lab space. "If we hadn't built it [the CAB], our competition schools
would have left us in the dust," says Richard P. Lifton, MD, chairman
of the genetics department.
Planning for the building
began in the late 1980s, but the Yale Corporation refused to authorize
funds for construction because of mounting budgetary woes at the
School. Since his arrival in 1997, Kessler focused on bringing fiscal
and administrative order to the School. Although no major donors
have stepped forth to help pay for the complex -- hence the current
generic name -- Yale determined that it could no longer wait.
"Kessler deserves a
lot of credit for gaining the University's confidence to get the
go-ahead for the new building," says Lifton. "It's a major tribute
to him."
Work began in early
2000, and the financing of the project was buoyed the next year
when Yale sold a substantial portion of the revenue stream generated
by licenses it held on the anti-AIDS drug Zerit. The sale netted
$115 million; about $60 million has reportedly been used to fund
the CAB.
The building,
which will be dedicated on May 2,
was designed by former School of Architecture teacher Robert Venturi,
of the Philadelphia firm of Venturi Scott Brown Associates (see sidebar), and the Boston firm Payette Associates.
The three-part complex is composed of two block-long wings that
meet in a soaring, stone-, brick-, and glass-walled lobby tucked
in from the corner of Congress Avenue and Cedar Street. A narrow,
raised central courtyard reaches out from the lobby to a lawn facing
New Haven's Hill neighborhood. The wings stretch back some 450 feet
to Howard Avenue and squeeze within a narrow block south to Gilbert
Street. Already the Congress Avenue and Cedar Street corner has
formed a new center of gravity for the medical campus.
That shift from the
Sterling Hall of Medicine front door at 333 Cedar Street reflects
a real change for the Medical School. Many of its most important
activities are moving to the new building. Over the course of a
complex marathon move taking place this winter, the contents of
91 laboratories, amounting to more than 200,000 separate pieces
of equipment (including hazardous biological materials requiring
special handling), are being packed up and hauled to the six-story
south wing. Nearly a quarter of the wing's laboratory space is reserved
for new faculty being recruited to the School.
A new pedestrian bridge
over Congress Avenue connects the three-story north wing to the
rest of the medical center. The wing contains the major teaching
laboratories in anatomy and histology, along with a 152-seat auditorium
and ten small conference rooms, all with state-of-the-art workstations.
"It's not just that
[the new laboratories] look nice and don't smell bad," says Herbert
S. Chase, MD, professor of medicine and deputy dean for education.
"Students will bump into somebody who just gave a lecture on the
way to his or her lab. Rubbing shoulders with scientists will shape
the way students think about the curriculum."
| |
The Animal Resources Center offers
facilities for the production of genetically altered mice.
|
The complex will also
draw scientists and students from as far away as Science Hill. Space
beneath the lobby and courtyard houses core research facilities
that serve the entire University. Below ground, the warehouse-size
Animal Resources Center offers facilities for the production of
genetically altered mice, an essential tool for biological science,
and supports a vivarium for 74,000 rodents. The Magnetic Resonance
Research Center (MRRC) takes up two levels above it and will eventually
house nine magnets for imaging studies of humans, animals, and cells.
The expanded facility will erase the present year-long wait researchers
have for magnet time, and the new magnets will greatly enhance what
their experiments can "see."
"We'll be able to move
from imaging systems down to actual biological processes," says
MRRC director Douglas L. Rothman, associate professor of diagnostic
radiology. "For instance, as opposed to saying a region of the brain
is not functioning properly in neural imaging studies, we could
say which specific neuronal circuit or neurochemical pathway within
that region is not functioning."
Hundreds of windows
light the loftlike lab space within the south wing, which is crowned
by a two-story roof and industrial-style smokestacks that house
ventilation and other mechanical systems. The wing hinges inward
along its length, increasing the density of scientists working within.
"You collaborate best by being close to one another," says Broadus.
Many
of the people moving to the CAB come from the department of internal
medicine's research sections. The south wing will be home
to two basic science programs -- a new Center for Human Genetics
and Genomics (CHGG) and the section of immunobiology -- and programs
focused on seven disease areas such as arthritis and autoimmunity,
infectious disease, and vascular disease and cardiology. These were
selected to capitalize on Yale's strengths and to encourage work
that translates basic science into medical advances.
Child psychiatrist
State will share lab space with Lifton, CHGG director, and other
Center researchers who understand the complex interactions of genes
and know how to apply emerging technologies to explain them. During
the last decade, Lifton, the Sterling Professor of Genetics, took the eccentric path of studying rare
forms of hypertension in his search for a genetic basis for the
disease. The strategy paid off, and now the scientist is searching
for the larger family of genes that control blood pressure.
"From the moment I
arrived at Yale, Rick's work seemed to be a really important example
of how to approach child psychiatric disorders," says State, who
is pursuing a similar pathway -- identifying individual children
or families with uncommon forms of psychiatric disorders and collaborating
with colleagues in a variety of areas. "It's an approach synergism
-- when something comes up, being literally across the hall decreases
barriers."
According to Broadus,
this is just what the building's planning committee had in mind.
"This is the golden age of biology," he says. "Young scientists
don't feel confined by section or department. They go where the
science takes them."
The hope is the Congress
Avenue Building will take them as fast as possible to cures.  |